Conversely, the HCC biomarker AFP-L3 [5] and the fibrosis marker ACE2 [56] showed significantly elevated serum levels in HCC compared with fibrosis or cirrhosis. This evidence concerns the gene ACE2 and hepatocellular carcinoma.